Chronic hand eczema, which can develop from chemicals and cleansers that people use frequently for work, now has its first FDA-approved treatment. The new LEO Pharma drug, Anzupgo, is a topical cream designed to block four signaling proteins that drive inflammation. The post LEO Pharma Topical Cream Is Now the First FDA-Approved Drug for Chronic Hand Eczema appeared first on MedCity News.

View Entire Post